X-74742184-T-G
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The ENST00000055682.12(NEXMIF):āc.2373A>Cā(p.Thr791=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00065 in 1,209,894 control chromosomes in the GnomAD database, including 3 homozygotes. There are 203 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. T791T) has been classified as Likely benign.
Frequency
Consequence
ENST00000055682.12 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEXMIF | NM_001008537.3 | c.2373A>C | p.Thr791= | synonymous_variant | 3/4 | ENST00000055682.12 | NP_001008537.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEXMIF | ENST00000055682.12 | c.2373A>C | p.Thr791= | synonymous_variant | 3/4 | 1 | NM_001008537.3 | ENSP00000055682 | P1 | |
NEXMIF | ENST00000616200.2 | c.2373A>C | p.Thr791= | synonymous_variant | 3/5 | 1 | ENSP00000480284 | P1 | ||
NEXMIF | ENST00000642681.2 | c.2373A>C | p.Thr791= | synonymous_variant | 3/3 | ENSP00000495800 |
Frequencies
GnomAD3 genomes AF: 0.00342 AC: 382AN: 111833Hom.: 2 Cov.: 23 AF XY: 0.00309 AC XY: 105AN XY: 33997
GnomAD3 exomes AF: 0.000961 AC: 176AN: 183181Hom.: 1 AF XY: 0.000517 AC XY: 35AN XY: 67701
GnomAD4 exome AF: 0.000370 AC: 406AN: 1098007Hom.: 1 Cov.: 31 AF XY: 0.000275 AC XY: 100AN XY: 363387
GnomAD4 genome AF: 0.00341 AC: 381AN: 111887Hom.: 2 Cov.: 23 AF XY: 0.00302 AC XY: 103AN XY: 34061
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 14, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 13, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2014 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at